Form Bio’s Post

💡Is Charles River Laboratories the right #CDMO partner for you? ➡ Supported the development of 86% of #FDA approved drugs over last 5 years ➡ Supported the development of 11 FDA approved #cellandgene therapies ➡ Integrated platform and service portfolio Incl. #Research, #Discovery, #Safety, #Testing and #Regulatory ➡ 30+ years of integrated #CGT testing and manufacturing capabilities Incl. #plasmid and #viralvector ➡ Founded in 1947 #science #research #lifesciences #biotechnology #scienceandtechnology #genetherapy

Commercialising cell and gene therapies - what is the way forward? As cell and gene therapies begin to move into the clinic, there is a growing attention on the need to improve their complex manufacturing processes. How can we create a system that addresses these challenges and use it to navigate efficiently through the intricate landscape of cell and gene therapy manufacturing? Olympia Pachoumi, PhD, Michaella (Kella) Kapnisi, Ph.D and Laureline MAHE explore a methodology for successful bioprocess development in their new blog: https://lnkd.in/ee_QWAJk #CGTs #cellandgenetherapies #processanalyticaltechnology #PATframework

We are proud to be recognised in the BioIndustry Association (BIA) Cell and Gene Therapy report, which outlines the UK’s pivotal role in advancing life-changing cell and gene therapy research to deliver transformative outcomes for patients living with debilitating or life-shortening conditions. To date, there has been a lack of innovation in treatment options for chronic kidney disease, despite a patient population of over 840 million people worldwide. Purespring’s novel  gene therapy platform, which delivers a disease-modifying gene directly to the podocyte, has the potential to make a real difference to the lives of patients around the world. For more information on the UK’s thriving #CellandGeneTherapy ecosystem, read the full report here: https://lnkd.in/dZJ_4H4Y #GeneTherapy #CellandGeneUK #Biotech #KidneyDiseases

🌟 Benefits of attending "Stability & Shelf Life Of Cell & Gene Therapy Products" 🌟 Understand: - Bracketing and matrixing to improve your product stability - Guidance and expectations for product stability protocol - Proper analytical methods for stability assessment - Requirements for Excipients and Diluents Learn from experts Matthias Renner and Dr. Robert Zoubek: - Gain a comprehensive overview on stability and shelf-life regulatory landscape - In depth insights into cell and gene therapy products - Network with key leaders and regulatory authority Don't miss out on this valuable opportunity to enhance your knowledge and connections in the field of cell and gene therapy products! 🚀 Register now 👉 https://lnkd.in/dZ7pGfCv #CellTherapy #GeneTherapy #Stability #ShelfLife #RegulatoryLandscape

Droplet digital PCR (ddPCR) is quickly becoming a mainstay of gene therapy. But scientists are struggling with data handling. Discover how the Tetra Scientific Data and AI Cloud™ streamlines ddPCR workflows, improving scientific outcomes in gene therapy. https://lnkd.in/ep9NFZTC #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes

𝑾𝒐𝒓𝒍𝒅’𝒔 𝒇𝒊𝒓𝒔𝒕 𝒈𝒆𝒏𝒆 𝒕𝒉𝒆𝒓𝒂𝒑𝒚 𝒇𝒐𝒓 𝒂 𝒓𝒂𝒓𝒆 𝒓𝒆𝒕𝒊𝒏𝒂𝒍 𝒅𝒊𝒔𝒆𝒂𝒔𝒆 Fantastic news from the world of gene therapy! AAVantgarde Bio is embarking on an exciting phase 1/2 clinical trial to treat retinitis pigmentosa associated with Usher syndrome type 1B. The groundbreaking procedure, carried out in Naples (Italy), was made possible by an innovative gene therapy platform developed by TIGEM in Pozzuoli, which enables the transfer of large genes. This cutting-edge technique, called “dual-AAV,” uses two AAV-like vectors, each carrying half of the genetic blueprint needed to create the therapeutic protein. Once inside the cell, these halves combine, allowing the protein to be produced in the right amounts, opening up thrilling possibilities for treatment! 👉 https://lnkd.in/dum9qQdA #GeneTherapy #RetinitisPigmentosa #UsherSyndrome #AAVantgardeBio #TIGEM #DualAAV   #MedicalInnovation #RareDiseaseResearch 

SCIEX Webinar: how LC-MS and CE Technology can help in Cell & Gene Therapy Analysis

Don't miss this webinar from SCIEX and SCIEX Biopharma & Pharma Solutions! Learn how SCIEX analytical instrumentation brings easier characterization to your cell and gene therapy workflow:

Want to learn how to purify different gene therapies modalities including pDNA, AAV, LV & exosomes? Sign up for the Chromatography + Filtration Virtual Summit to listen and discuss with experts from the gene therapy community on March 7 https://lnkd.in/ehZcKyft #chromatography #filtration #genetherapy #viralvector